Oral Desensitization to Peanut in Peanut Allergic Children and Adults Using CPNA Peanut OIT Safety Follow-On Study
Completed · Phase 2 · Has a placebo group
Conditions studied: Peanut Allergy
In brief
This is a multi-center, open-label, follow-on study to gather additional information on the safety and tolerability of oral desensitization with CPNA in the subjects who participated in ARC001.
Key facts
- Study ID
- NCT02198664
- Run by
- Aimmune Therapeutics, Inc.
- People needed
- 47
- Starts
- 2014-08-27
- Expected to finish
- 2018-01-04
- Last updated by the study team
- 2021-11-09
Who can join
Age: 4 and older, up to 26. Sex: any. Healthy volunteers: not accepted.
Where it is running
- Arkansas Children's Hospital — Little Rock, Arkansas, United States
- UC San Diego — San Diego, California, United States
- Boston Children's Hospital — Boston, Massachusetts, United States
- Mount Sinai Medical Center — New York, New York, United States
- University of North Carolina Chapel HIll — Chapel Hill, North Carolina, United States
- Cincinnati Children's Hospital Medical Center — Cincinnati, Ohio, United States
- The Children's Hospital of Philadelphia — Philadelphia, Pennsylvania, United States
- Children's Medical Center Dallas — Dallas, Texas, United States
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.